Risks of Adverse Effects, Deaths and Product Liability
First written in FY2021. 1 of 2 entries say "Restated". Latest entry: FY2022.
The whole theme swung hardest in 2026: 6 of 20 companies on the "Worse" side.
36 other companies' latest entry also says "Restated".
- FY2022RestatedAnnual report
「If serious adverse effects or fatalities result in product recalls, discontinuation of manufacturing and sales, pharmaceutical injury litigation, product liability damages or an impact on other businesses, this may have a material effect on our financial position and operating results.」
The company continues to disclose the risks of adverse effects, fatalities, recalls, discontinuation of sales and litigation, among other events. - FY2021First statedAnnual report
「Pharmaceutical products may cause unforeseen adverse effects from the clinical trial stage through the post-launch period. If serious adverse effects or fatalities result in product recalls, discontinuation of manufacturing and sales, pharmaceutical injury litigation, product liability damages or an impact on other businesses, this may have a material effect on our financial position and operating results.」
The company discloses the possibility of adverse effects identified after launch, recalls, discontinuation of sales and litigation, among other events.